The estimated Net Worth of Paul D Bloom is at least $1.15 Million dollars as of 22 August 2024. Dr Bloom owns over 60,303 units of Gevo Inc stock worth over $705,873 and over the last 4 years he sold GEVO stock worth over $439,516.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr Bloom GEVO stock SEC Form 4 insiders trading
Dr has made over 7 trades of the Gevo Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 60,303 units of GEVO stock worth $45,830 on 22 August 2024.
The largest trade he's ever made was selling 87,253 units of Gevo Inc stock on 23 August 2023 worth over $120,409. On average, Dr trades about 23,408 units every 56 days since 2021. As of 22 August 2024 he still owns at least 953,882 units of Gevo Inc stock.
You can see the complete history of Dr Bloom stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Paul D. Bloom biography
Dr. Paul D. Bloom is the CTO & Chief Innovation Officer at Gevo Inc.
How old is Dr Bloom?
Dr Bloom is 47, he's been the CTO & Chief Innovation Officer of Gevo Inc since . There are 18 older and 1 younger executives at Gevo Inc. The oldest executive at Gevo Inc is William Baum, 75, who is the Independent Director.
What's Dr Bloom's mailing address?
Paul's mailing address filed with the SEC is C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD, CO, 80112.
Insiders trading at Gevo Inc
Over the last 14 years, insiders at Gevo Inc have traded over $8,792,869 worth of Gevo Inc stock and bought 245,370 units worth $712,223 . The most active insiders traders include Andrew Marsh, Stacy J Smith und Johannes Minho Roth. On average, Gevo Inc executives and independent directors trade stock every 10 days with the average trade being worth of $6,817. The most recent stock trade was executed by Kimberly T Bowron on 22 August 2024, trading 16,383 units of GEVO stock currently worth $12,451.
What does Gevo Inc do?
gevo is a leading renewable chemicals and advanced biofuels company. we are developing biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. we plan to produce isobutanol, a versatile platform chemical for the liquid fuels and petrochemical market. isobutanol has broad market applications as a solvent and a gasoline blendstock that can help refiners meet their renewable fuel and clean air obligations. it can also be further processed using well-known chemical processes into jet fuel and feedstocks for the production of synthetic rubber, plastics, and polyesters. gevo's technology was designed to retrofit existing ethanol plants of all kinds.
What does Gevo Inc's logo look like?
Complete history of Dr Bloom stock trades at Gevo Inc
Gevo Inc executives and stock owners
Gevo Inc executives and other stock owners filed with the SEC include:
-
Patrick Gruber,
Chief Executive Officer, Director -
Tim Cesarek,
Chief Commercial Officer -
Christopher Ryan,
President, Chief Operating Officer, Chief Technology Officer -
Dr. Patrick R. Gruber M.B.A., Ph.D., MBA,
CEO & Director -
Timothy J. Cesarek,
Chief Commercial Officer -
Dr. Christopher M. Ryan,
Pres & COO -
Geoffrey Williams,
General Counsel, Secretary -
Ruth Dreessen,
Independent Chairman of the Board -
Shawn Severson,
Investors Relation -
Johannes Roth,
Independent Director -
Gary Mize,
Independent Director -
Andrew Marsh,
Independent Director -
William Baum,
Independent Director -
Carolyn Romero,
Vice President – Controller -
L. Lynn Smull,
Chief Financial Officer -
Kimberly T. Bowron SPHR,
Chief People Officer -
Alisher Nurmat CPA,
Principal Accounting Officer, VP & Controller -
Kimberly Bowron,
Chief HR Officer -
Dr. Paul D. Bloom,
CTO & Chief Innovation Officer -
Carolyn M. Romero CPA,
Chief Accounting Officer -
L. Lynn Smull,
Chief Financial Officer -
Geoffrey Thomas Williams Jr., BA, J.D.,
VP, Gen. Counsel & Sec. -
Heather Manuel,
VP o Investor Relations & Communications -
Prof. James C. Liao Ph.D.,
Co-Founder -
Andrew Shafer,
Chief Mktg Cust & Brnd Officer -
Mike Willis,
Interim CFO -
Gregory Roda,
Chief Commercial Officer -
Angelo Amorelli,
Director -
Mary Kathryn Ellet,
Director -
Samir Kaul,
Director -
I Ltd Vgf Partners I, L.P.V...,
-
Carol Jane Battershell,
Director -
Bradford K Towne,
Chief Accounting Officer -
Ganesh Kishore,
Director -
Ventures I, L.P.Khosla Vent...,
-
Bruce A Smith,
Director -
Samir Khosla Ventures I, L....,
-
Carlos A. Cabrera,
Director -
Brett Lund,
EVP, Gen. Counsel & Secretary -
Stacy J Smith,
Director -
David Glassner,
Executive VP, Technology -
Mark L Smith,
Chief Financial Officer -
Shai Weiss,
Director -
Brant De Muth,
EVP, Strategy and Corp. Dev. -
Ventures Iii, L.P.Khosla Vi...,
-
David Black,
EVP, Upstream Business Dev. -
Jack Huttner,
EVP,Co Development&Pub Affairs -
Michael Slaney,
EVP, Upstream Business Dev. -
Jaime Guillen,
Director -
Kimberly T Bowron,
Chief People Officer -
Alisher K Nurmat,
VP AND TREASURER -
Paul D Bloom,
CCO & CIO